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Abstract
Background: Many acute respiratory illness surveillance systems collect and test nasopharyngeal (NP) and/or oropharyn-
geal (OP) swab specimens, yet there are few studies assessing the relative measures of performance for NP versus OP
specimens.
Methods: We collected paired NP and OP swabs separately from pediatric and adult patients with influenza-like illness or
severe acute respiratory illness at two respiratory surveillance sites in Kenya. The specimens were tested for eight respiratory
viruses by real-time reverse transcription-polymerase chain reaction (qRT-PCR). Positivity for a specific virus was defined as
detection of viral nucleic acid in either swab.
Results: Of 2,331 paired NP/OP specimens, 1,402 (60.1%) were positive for at least one virus, and 393 (16.9%) were positive
for more than one virus. Overall, OP swabs were significantly more sensitive than NP swabs for adenovirus (72.4% vs. 57.6%,
p,0.01) and 2009 pandemic influenza A (H1N1) virus (91.2% vs. 70.4%, p,0.01). NP specimens were more sensitive for
influenza B virus (83.3% vs. 61.5%, p=0.02), parainfluenza virus 2 (85.7%, vs. 39.3%, p,0.01), and parainfluenza virus 3
(83.9% vs. 67.4%, p,0.01). The two methods did not differ significantly for human metapneumovirus, influenza A (H3N2)
virus, parainfluenza virus 1, or respiratory syncytial virus.
Conclusions: The sensitivities were variable among the eight viruses tested; neither specimen was consistently more
effective than the other. For respiratory disease surveillance programs using qRT-PCR that aim to maximize sensitivity for a
large number of viruses, collecting combined NP and OP specimens would be the most effective approach.
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Introduction
Acute respiratory illness (ARI) is a significant cause of mortality
and morbidity worldwide, especially in young children [1]. Viruses
play an important role in ARI, accounting for up to 90% of lower
respiratory tract infections in children , 5 years [2].
A variety of sample collection techniques and specimen
sources can be used to detect respiratory etiologies, including
nasopharyngeal (NP) swabs, oropharyngeal (OP) swabs, naso-
pharyngeal aspirates (NPAs), nasal swabs, nasal washes, sputa,
and saliva specimens. Although NPAs may be the most sensitive
specimens, especially when conventional diagnostic methods
such as immunofluorescence or culture are used [3], obtaining
an NPA is more difficult than obtaining a swab, and collecting
NPAs in an outpatient or field setting may not always be feasible
[4,5]. Molecular methods like reverse transcription-polymerase
chain reaction (RT-PCR) are becoming widely used for
identification of respiratory etiologies [6]. Because molecular
tests are more sensitive than conventional methods, less invasive
specimen collection techniques than NPA may now approach
comparable yields [5,7].
Depending upon patient characteristics, especially age, obtain-
ing either – or both – NP and OP swabs can be quite physically
challenging. Using only one type of swab would be easier logis-
tically, cheaper, and would enable comparisons across surveillance
systems. To evaluate the comparative yields of NP and OP swabs
in detecting key respiratory viruses by real-time RT-PCR (qRT-
PCR), we conducted a prospective study using paired NP and OP
specimens from patients at two respiratory disease surveillance
sites in Kenya.
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Ethics Statement
Ethical approval for the surveillance activities for influenza and
other respiratory viruses was obtained from the Kenya Medical
Research Institute (KEMRI) Ethical Review Committee (protocol
number 1161). After formal human subjects determination, U.S.
Centers for Disease Control and Prevention (CDC) determined
this surveillance activity to be nonresearch and therefore approval
was not required from the CDC Institutional Review Board.
Written informed consent was obtained from adults and from the
parents or guardians of minors.
Study population
The study population consisted of pediatric and adult patients
visiting two health-care sites from June 9, 2009 to August 31, 2010,
whose illness met the case definition for influenza-like illness (ILI)
or severe acute respiratory illness (SARI). The case definitions for
ILI and SARI (Table 1) were adapted from those of the World
Health Organization [8,9]. The maximum number of eligible ILI
patients was limited to three per day for each site; there was no
limit to the number of SARI patients tested. The health-care sites
are in the North Eastern and Rift Valley provinces of Kenya and
are part of a wider national influenza sentinel surveillance system
run jointly by the Kenya Ministry of Public Health and Sanitation
and KEMRI/Centers for Disease Control and Prevention-Kenya
(CDC-K).
Specimen collection
NP and OP swabs were separately collected from patients with
ILI or SARI by trained surveillance officers. For the NP swab, a
polyester-tipped flexible aluminum-shafted applicator (25-801D,
Puritan, Guilford, Maine, USA) was inserted into one of the
nostrils until resistance was felt at the nasopharynx, then rotated
180 degrees and withdrawn. For the OP swab, a nylon flocked
plastic-shafted applicator (503CS01, Copan Diagnostics, Murrieta,
CA, USA) was used to sample the posterior oropharyngeal
mucosal membrane. After swabbing, the swab applicator was cut
off, and each absorbent swab was placed into a vial containing
1 mL of viral transport media (VTM). VTM was prepared at the
KEMRI/CDC-K laboratory using standard WHO protocol [10].
Vials were stored at 4uC for up to 72 hours until before shipment
to the KEMRI/CDC-K laboratory in Nairobi, where they were
stored at 280uC until testing.
Testing for respiratory viruses
The specimens were vortexed, and a 100-mL volume was used for
total nucleicacid extractionusing the QIAamp ViralRNAMini Kit
(QiagenGmbH,Hilden,Germany)accordingtothemanufacturer’s
instructions. One step qRT-PCR was performed by using the
AgPath-ID One-Step RT-PCR Kit (Applied Biosystems, Carlsbad,
California, USA). NP and OP specimens from each patient were
separately tested by singleplex qRT-PCR for eight viral pathogens:
adenovirus, influenza A virus, influenza B virus, human metapneu-
movirus (hMPV), parainfluenza viruses (PIV) 1–3, and respiratory
syncytial virus (RSV). The primers, probes and positive controls for
all viruses were provided by CDC-Atlanta. Sequences for the
primers and probes are shown in Table 2 [11]. We tested for
influenza A virus with the conserved matrix gene-base qRT-PCR;
positive influenza A samples were also subtyped as 2009 pandemic
influenza A (H1N1) virus (2009 H1N1), influenza A (H3N2) virus
(H3N2), and seasonal influenza A (H1N1) virus (H1N1) [12].
Fluorescence was read at the combined annealing-extension step at
57uC and recorded as threshold cycle (Ct) values. A Ct value #39.9
was regarded as positive; Ct values $40.0 were regarded as
negative. The qRT-PCR test did not discriminate between viral
mRNA and genomic RNA. Specimens were not tested if the
following conditions existed when the specimen arrived at the lab:
there was no swab, the volume was less than 600 mL, the specimen
was at room temperature, patient identification was absent or
inadequate,orthepatientquestionnaire wasabsent.In addition, the
test results were discarded for any specimen whose internal control
(human ribonuclease P gene) was negative.
Statistical analysis
Agreementofthe resultsbetween thepaired NP and OP specimens
was assessed by using the kappa coefficient. We used the following
nomenclature to describe the relative strength of agreement
associated with kappa statistics: , 0 = poor; 0–0.2 = slight; 0.21–
0.4 = fair; 0.41–0.6 = moderate; 0.61–0.8 = substantial; and 0.81–
1=a l m o s tp e r f e c t[ 1 3 ] .T h ea s s e s s m e n tw a sc a r r i e do u ts e p a r a t e l y
for each respiratory virus and for each of the influenza A subtypes.
Similar to previous studies [5,7], we assessed the sensitivity for
each sampling method by considering any positive from either of
the specimens as a true positive. We compared the sensitivities
using the McNemar’s test to account for the correlated binary
Table 1. Case definitions of influenza-like illness and severe
acute respiratory infection adapted from World Health
Organization
1, 2
Influenza-like illness (ILI)
All ages (all of the following):
1. Temperature $38u
2. Cough or sore throat
3. Does not meet criteria for SARI
Severe Acute Respiratory Infection (SARI)
For infants ages 1 week to , 2 months (any of the following):
N Respiratory rate of .60 per minute
N Severe chest indrawing
N Nasal flaring (when an infant breathes in)
N Grunting (when an infant breathes out)
N Temperature $38uC
N Temperature ,35.5uC
N Pulse oxygenation ,90%
For children ages 2 months to ,5 years:
1. Cough or difficulty breathing
2. AND any one of the following:
N Breathing .50/minute for infant aged 2 months to ,1year
N Breathing .40/minute for child aged 1 to ,5 years
N Chest indrawing or stridor in a calm child
N Unable to drink or breast feed
N Vomits everything
N Convulsions
N Lethargic or unconscious
N Pulse oxygenation ,90%
For persons ages $5 years (all of the following):
1. Temperature $38.0uC
2. Cough or sore throat
3. Shortness of breath or difficulty breathing
1. World Health Organization. Handbook: IMCI Integrated Management of
Childhood Illness 2005. Available from: http://whqlibdoc.who.int/publications/
2005/9241546441.pdf.
2. World Health Organization. WHO Regional Office for Europe guidance for
influenza surveillance in humans. 2009. Available from: http://www.euro.who.
int/__data/assets/pdf_file/0020/90443/E92738.pdf.
doi:10.1371/journal.pone.0021610.t001
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used the exact binomial confidence limits. Statistical significance
was set at a p-value ,0.05. Data were analyzed with SAS software
version 9.2 (SAS Institute, Cary, NC, USA).
Results
During the study period, 2,374 paired NP and OP swabs were
collected. Forty-three specimens were rejected because of poor
quality. Of the 2,331 paired specimens included in the analysis,
754 (32.3%) were from patients with ILI and 1,577 (67.7%) were
from patients with SARI. Overall, 1,402 (60.1%) paired specimens
were positive for at least one virus, including 393 (16.9%)
specimens that were positive for more than one virus. The median
number of days from onset of symptoms to specimen collection
was 2 days, and 95.9% of samples were collected within 5 days
from onset of symptoms (range 0–30 days). The median age of
patients was 1 year (range 1 month to 70 years), and 81.6% of
patients (n=1,902) were less than 5 years old (Table 3). Fewer
than half (46.1%) of the patients were female (n=1,074).
Adenovirus was the most commonly identified virus, detected in
$1 specimens from 679 (29.1%) patients (Table 4).
For all patients combined (ILI and SARI), the relative
sensitivities of the swab types varied by virus (Table 4). OP swabs
were significantly more sensitive in detecting influenza A virus
(85.9% vs. 70.7%, p ,0.01), yet sensitivities differed for influenza
A subtypes; OP swabs were more sensitive for 2009 H1N1 (91.2%
vs. 70.4%, p,0.01), but did not differ from NP swabs in detecting
H3N2. OP swabs also were significantly more sensitive than NP
swabs for detecting adenovirus (72.4% vs. 57.6%, p,0.01).
However, NP swabs had significantly higher sensitivities than
OP swabs for influenza B virus (83.3% vs. 61.5%, p=0.02), PIV
2 (85.7%, vs. 39.3%, p,0.01) and PIV 3 (83.9% vs. 67.4%,
p,0.01). The difference in sensitivity for the two types of
specimens did not reach statistical significance for hPMV, PIV
1, RSV, H3N2 virus, or unsubtypable influenza A viruses.
For all SARI patients (n=1,577), OP swabs were significantly
more sensitive than NP swabs for adenovirus and 2009 H1N1
virus, but NP swabs were more sensitive than OP swabs for
influenza B virus, PIV 2, and PIV 3. For all ILI patients (n=754),
OP swabs were more sensitive than NP swabs for adenovirus and
overall influenza A virus; NP swabs were not more sensitive than
OP swabs for any of the viruses in this illness category (Table 5).
The relative sensitivities of NP and OP swabs from children , 5
years old (n=1,902) mirrored the overall results. When results in
this age group were stratified by SARI and ILI, the comparative
sensitivities for NP and OP swabs reached statistical significance in
the same pattern as that for all SARI and ILI patients. However,
for patients aged 5–17 years (n=344) and for patients 18 years and
older (n=85), neither swab was significantly more sensitive for any
of the viruses, including when results were stratified by SARI and
ILI status. For male patients (n=1,257), specimen performance
for all viruses mirrored the overall results. For female patients
(n=1,074), as with the overall results, OP swabs were significantly
more sensitive than NP swabs for influenza A virus and adeno-
virus, while NP swabs were significantly more sensitive than OP
swabs for PIV 2; however, there was no statistical difference by
swab type for 2009 H1N1 virus, influenza B virus, and PIV 3.
There was a substantial agreement (k.0.60) between the NP
and the OP swabs for all viruses except adenovirus, unsubtypable
influenza viruses, PIV 1, and PIV 2 (Table 4). PIV 1 had a
moderate strength of agreement (k=0.59) between swabs, but
adenovirus and PIV 2 had only a fair strength of agreement
(k=0.33 and 0.39, respectively). Unsubtypable influenza viruses
had poor strength of agreement (k=20.68). If only the more
Table 2. Primers and probes used in this study.
Assay
1 Primer/Probe Sequence (59 to 39)
Adenovirus F
2 GCC CCA GTG GTC TTA CAT GCA CAT C
R
3 GCC ACG GTG GGG TTT CTA AAC TT
P
4 FAM-TGC ACC AGA CCC GGG CTC AGG TAC TCC GA
hMPV F CAA GTG TGA CAT TGC TGA YCT RAA
R ACT GCC GCA CAA CAT TTA GRA A
P FAM-TGG CYG TYA GCT TCA GTC AAT TCA ACA GA
Influenza A F GAC CRA TCC TGT CAC CTC TGA C
R AGG GCA TTY TGG ACA AAK CGT CTA
P FAM-TGC AGT CCT CGC TCA CTG GGC ACG
Influenza B F TCC TCA ACT CAC TCT TCG AGC G
R CGG TGC TCT TGA CCA AAT TGG
P FAM-CCA ATT CGA GCA GCT GAA ACT GCG GTG
PIV type 1 F AGT TGT CAA TGT CTT AAT TCG TAT CAA T
R TCG GCA CCT AAG TAA TTT TGA GTT
P FAM-ATA GGC CAA AGA ‘‘T’’TG TTG TCG AGA CTA TTC CA
5
PIV type 2 F GCA TTT CCA ATC TAC AGG ACT ATG A
R ACC TCC TGG TAT AGC AGT GAC TGA AC
P FAM-CCA TTT ACC ‘‘T’’AA GTG ATG GAA TCA ATC GCA AA
PIV type 3 F TGG YTC AAT CTC AAC AAC AAC AAG ATT TAA G
R TAC CCG AGA AAT ATT ATT TTG CC
P FAM-CCC ATC TG‘‘T’’ TGG ACC AGG GAT ATA CTA CAA A
RSV F GGC AAA TAT GGA AAC ATA CGT GAA
R TCT TTT TCT AGG ACA TTG TAY TGA ACA G
P FAM-CTG TGT ATG TGG AGC CTT CGT GAA GCT
1. hMPV, human metapneumovirus; PIV, parainfluenza virus; RSV, respiratory
syncytial virus.
2. F, forward primer.
3. R, reverse primer.
4. P, probe.
5. ‘‘T’’, internal quencher.
doi:10.1371/journal.pone.0021610.t002
Table 3. Demographic characteristics of 2331 patients with
influenza-like illness and severe acute respiratory illness from
whom paired nasopharyngeal and oropharyngeal swabs were
collected – Kenya, 2009–2010.
Category Subcategory N (%)
Illness Severe acute respiratory illness 1577 (67.7%)
Influenza-like illness 754 (32.3%)
Age Median 1 year
Range 1 month–70 years
,5 years 1902 (81.6%)
5–17 years 344 (14.8%)
.18 years and older 85 (3.6%)
Sex Female 1074 (46.1%)
Male 1257 (53.9%)
Location North Eastern Province 1233 (52.9%)
Rift Valley Province 1098 (47.1%)
doi:10.1371/journal.pone.0021610.t003
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ferences in sensitivities between swabs, 8.8% –27.5% of cases
would have been missed compared to using both swabs. For
adenovirus, 72.5% of the total cases detected by using both swabs
would have been identified by using the more sensitive OP swab;
similarly, 85.9% of all influenza A virus, 91.2% of 2009 H1N1
virus, 84.6% of influenza B virus, 85.7% of PIV 2, and 83.9% of
PIV 3 cases would have been detected if only the single, more
sensitive swab had been used (Table 4).
Discussion
To our knowledge, this is the largest study to use qRT-PCR to
compare NP and OP swabs for a range of respiratory viruses. We
found that the relative performance of specimen type varied by
virus. Neither specimen performed uniformly better: NP swabs
were more sensitive for some viruses (influenza B virus, PIV 2, and
PIV 3), OP swabs were more sensitive for others (overall influenza
A virus, 2009 H1N1 virus, and adenovirus), and there was no
difference for the rest of the viruses. The large number of patients
in this study allowed us to perform comparative statistical analysis
with a relatively high degree of precision.
For adenovirus, OP swabs were more sensitive than NP swabs, a
finding that was statistically significant in both ILI and SARI
patients. This difference may reflect the fact that the major site of
initial replication of adenoviruses is the non-ciliated respiratory
epithelium of the oropharynx [14]. The kappa value between NP
and OP swabs for adenovirus was low (k=0.33). This result is
consistent with findings of Lambert et al., in which adenovirus
accounted for the highest proportion of discordant paired NPA
and nasal-throat swab specimens from children [7]. Adenoviruses
include over 50 serotypes, and the low concordance between NP
and OP specimens for these viruses may reflect different cell
tropisms of the adenovirus serotypes for different parts of the
respiratory tract [15]. Although we did not conduct serotyping,
future studies that evaluate specimen performance for specific
adenovirus serotypes could test this hypothesis.
For influenza viruses, sensitivities of NP and OP swabs differed
by both type and subtype: NP swabs were more sensitive than OP
swabs for influenza B virus, while OP swabs were more sensitive
than NP swabs for overall influenza A and 2009 H1N1 virus; there
was no significant difference between swabs for H3N2 virus or the
unsubtypable influenza A viruses. The sensitivities of NP and OP
swabs for unsubtypable influenza A viruses were low, and the
strength of agreement between the two swabs was poor. However,
unsubtypable influenza A viruses were likely a mix of 2009 H1N1,
seasonal H1N1, and H3N2 viruses, making it difficult to interpret
this finding. Because half the influenza A specimens were 2009
H1N1, the overall influenza A results were biased towards the
2009 H1N1 findings. Previous studies evaluating NP and OP
swabs in detecting influenza viruses found NP swabs to be more
sensitive than OP swabs, but these studies used combined out-
comes for influenza A and B viruses and did not analyze by
influenza A subtypes [6,16,17]. The difference in sensitivities of the
two swabs in our study may reflect different affinities of influenza
types and subtypes for different locations in the respiratory tract.
While all influenza viruses infect the respiratory epitheliumfrom the
nasopharynxtothebronchioles,2009 H1N1 virus (and H5N1virus,
which we did not find in our study) can infect lower parts of the
respiratory tract, including the alveoli, more commonly than
seasonal influenza [18]. This difference could account for the better
sensitivity of OP swabs, which reach deeper into the respiratory
tract than NP swabs, for 2009 H1N1 virus. Of note, OP swabs have
been shown to have superior yield over NP swabs for human cases
of avian influenza A (H5N1) [19,20].
The OP swab sensitivities and kappa values of the parainfluenza
viruses were relatively low, with the sensitivity of the OP swab for
PIV 2 being the lowest of any virus in our study. This preference
for NP swabs is consistent with reports that nasal washes and nasal
aspirates have yielded the highest rates of viral recovery for PIV
[21].
This study had several limitations. First, we compared only NP
and OP swabs; although many routine surveillance systems for
Table 4. Kappa and sensitivity values of paired nasopharyngeal (NP) swabs and oropharyngeal (OP) swabs for respiratory viruses
in all patients (n=2331) – Kenya, 2009-2010.
Virus
1
No. positive NP
and/or OP swabs
No. positive NP
swabs
No. positive
OP swabs
% missed with
one swab
2
Kappa statistic
3
(95% CI)
NP sensitivity
(95% CI)
OP sensitivity
(95% CI) p-value
Adenovirus 679 391 492 27.5% 0.33 (0.28–0.38) 57.6 (53.8–61.4) 72.4 (68.8–75.7) , 0.01
hMPV 201 158 139 0.62 (0.55–0.69) 78.6 (72.3–84.1) 69.2 (62.3–75.5) 0.08
Influenza A 256 181 220 14.1% 0.70 (0.64–0.75) 70.7 (64.7–76.2) 85.9 (81.1–90) , 0.01
2009 H1N1 125 88 114 8.8% 0.75 (0.68–0.82) 70.4 (61.6–78.2) 91.2 (84.8–95.5) , 0.01
H1N1 6 6 5 0.9 (0.73–1.0) 100 (54.1–100) 83.3 (35.9–99.6) 1.00
H3N2 54 45 50 0.86 (0.79–0.94) 83.3 (70.7–92.1) 92.6 (82.1–97.9) 0.27
unsubtypable 71 33 48 -0.68 (-0.86–0.5) 46.5 (34.5–58.7) 67.6 (55.5–78.2) 0.07
Influenza B 65 55 40 15.4% 0.62 (0.51–0.74) 83.3 (72.1–91.4) 61.5 (48.6 -73.3) 0.02
PIV 1 106 81 71 0.59 (0.50–0.69) 76.4 (67.2–84.1) 67.0 (57.2-75.8) 0.24
PIV 2 56 48 22 14.3% 0.39 (0.25–0.54) 85.7 (73.8–93.6) 39.3 (26.5–53.2) , 0.01
PIV 3 193 162 130 16.1% 0.66 (0.59–0.72) 83.9 (78.0–88.8) 67.4 (60.3–73.9) , 0.01
RSV 328 252 247 0.65 (0.59–0.70) 76.8 (71.9–81.3) 75.3 (70.3–79.9) 0.75
12009 H1N1, 2009 influenza A pandemic H1N1 virus; H1N1, seasonal influenza A H1N1 virus; H3N2, influenza A H3N2; RSV, respiratory syncytial virus; PIV, parainfluenza
virus; hMPV, human metapneumovirus.
2The percentage of cases that would have been missed if only the more sensitive swab had been used for viruses which had significant differences in sensitivities
between swabs.
3Kappa statistics: , 0 = poor; 0 – 0.2 = slight; 0.21 – 0.4 = fair; 0.41 – 0.6 = moderate; 0.61 – 0.8 = substantial; and 0.81 – 1 = almost perfect agreement. CI,
confidence interval.
doi:10.1371/journal.pone.0021610.t004
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other surveillance systems collect NPAs, NP washes, or nasal swabs
[22]. While recent studies have used PCR to compare the relative
yield of NPAs with those of nose-throat swabs or nasal swabs for
respiratory viruses, no studies have evaluated more than three
sampling techniques [5,7,23,24]. Head-to-head studies in the
future comparing NP swab, OP swab, NPA, NP wash, nose-throat
swab, nasal swab, and nasal wash specimen types would provide
important information for decisions about which specimens to use
for respiratory disease surveillance systems. Second, the NP and
OP swabs consisted of different kinds of swab material and used
different designs. We used conventional polyester swabs for sam-
pling the nasopharynx and flocked nylon swabs for the oropharynx.
Although flocked swabs are superior to conventional swabs for cell
recovery, a study comparing different swab material and design
(rayon versus nylon flocked swabs) in both the nasopharynx and
oropharynx found that the difference in the cycle threshold values
between sampling sites was much greater than the difference
between swab material and design [25]. Because neither specimen
type was consistently more sensitive than the other, we think it is
unlikely that the difference in swab material and designsubstantially
affected our results. Additionally, while we tested for eight viruses,
we didnot include somecommonviruses, suchascoronaviruses and
rhinoviruses, and we did not test for bacteria. Finally, the number of
adults (n=85) in this study was relatively small, accounting for just
3.6% of all patients, and as a result there was limited power to
compare the sensitivities of NP and OP swabs for specific viruses in
this population.
In summary, NP and OP specimens collected from patients with
respiratory illness had variable sensitivities by qRT-PCR for eight
viruses. Neither specimen was consistently more sensitive than the
other. Collecting both swabs had a complementary effect; even
when there was higher sensitivity for one technique over the other,
the lower-sensitivity technique still identified a considerable num-
ber of cases not identified by the higher-sensitivity one. For
respiratory disease surveillance programs using qRT-PCR that
aim to maximize sensitivity for a large number of viruses, col-
lecting combined NP and OP specimens would be the ideal
approach. However, the enhanced sensitivity of using both swabs
comes at a higher cost; this includes not only the expense of the
second swab, but further patient discomfort as well as additional
time and effort from the person taking the sample. Thus, for
surveillance systems with limited resources, a single-swab ap-
proach, whether NP or OP, would be the most logistically simple
and maintain moderate sensitivity for many of the pathogens we
tested in our study.
Table 5. Kappa and sensitivity values of paired nasopharyngeal (NP) swabs and oropharyngeal (OP) swabs for respiratory viruses
by illness category – Kenya, 2009-2010.
Virus
1
No. positive NP
and/or OP swabs
No. positive
NP swabs
No. positive
OP swabs
% missed with
one swab
2
Kappa statistic
3
(95% CI)
NP sensitivity
(95% CI)
OP sensitivity
(95% CI) p-value
Severe acute respiratory illness (n=1577)
Adenovirus 515 308 367 28.7% 0.32 (0.27–0.38) 59.8 (55.4–64.1) 71.3 (67.1–75.1) ,0.01
hMPV 150 116 101 0.59 (0.51–0.67) 77.3 (69.8–83.8) 67.3 (59.2–74.8) 0.12
Influenza A 168 125 141 0.71 (0.65–0.78) 74.0 (66.7–80.4) 83.9 (77.5–89.1) 0.07
2009 H1N1 77 53 71 7.8% 0.75 (0.66–0.83) 68.8 (57.3–78.9) 92.2 (83.8–97.1) ,0.01
H3N2 41 35 37 0.86 (0.77–0.94) 85.4 (70.8–94.4) 90.2 (76.9–97.3) 0.75
Influenza B 40 35 23 12.5% 0.61 (0.47–0.76) 85.4 (70.8–94.4) 57.5 (40.9–73.0) 0.02
PIV 1 76 57 46 0.51 (0.39–0.63) 75.0 (63.7–84.2) 60.5 (48.6–71.5) 0.15
PIV 2 44 39 15 11.4% 0.36 (0.20–0.53) 88.6 (75.4–96.2) 34.1 (20.5–49.9) ,0.01
PIV 3 155 134 99 13.5% 0.64 (0.57–0.72) 86.5 (80.0–91.4) 63.9 (55.8–71.4) ,0.01
RSV 263 198 198 0.62 (0.56–0.68) 75.3 (69.6–80.4) 75.3 (69.6–80.4) 1.00
Influenza-like illness (n=754)
Adenovirus 164 83 125 23.8% 0.33 (0.24–0.42) 50.6 (42.7–58.5) 76.2 (69.0–82.5) ,0.01
hMPV 51 42 38 0.71 (0.59–0.82) 82.4 (69.1–91.6) 74.5 (60.4–85.7) 0.52
Influenza A 83 54 74 10.8% 0.68 (0.58–0.77) 65.5 (54.3–75.5) 89.5 (81.1––95.1) ,0.01
2009 H1N1 48 35 43 0.76 (0.65–0.86) 72.9 (58.2–84.7) 89.6 (77.3–96.5) 0.10
H3N2 13 10 13 0.87 (0.72–1.00) 76.9 (46.2–95.0) 100 (75.3–100.0) 0.25
Influenza B 25 20 17 0.64 (0.46–0.82) 80.0 (59.3–93.2) 68.0 (46.5–85.1) 0.58
PIV1 30 24 25 0.77 (0.63–0.90) 80.0 (61.4–92.3) 83.3 (65.3–94.4) 1.00
PIV2 12 9 7 0.49 (0.19–0.80) 75.0 (42.8–94.5) 58.3 (27.7–84.8) 0.73
PIV3 38 28 31 0.70 (0.56–0.84) 73.7 (56.9–86.6) 81.6 (65.7–92.3) 0.63
RSV 65 54 49 0.72 (0.62–0.82) 83.1 (71.7–91.2) 75.4 (63.1–85.2) 0.44
12009 H1N1, 2009 influenza A pandemic H1N1 virus; H1N1, seasonal influenza A H1N1 virus; H3N2, influenza A H3N2; RSV, respiratory syncytial virus; PIV, parainfluenza
virus; hMPV, human metapneumovirus.
2The percentage of cases that would have been missed if only the more sensitive swab had been used for viruses which had significant differences in sensitivities
between swabs.
3Kappa statistics: ,0 = poor; 0–0.2 = slight; 0.21–0.4 = fair; 0.41–0.6 = moderate; 0.61–0.8 = substantial; and 0.81–1 = almost perfect agreement. CI, confidence
interval.
doi:10.1371/journal.pone.0021610.t005
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